Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 29, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, compliance, foreign-issuer
TL;DR
DRL filed a 6-K on Nov 29, 2024, standard reporting for foreign issuers.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 29, 2024, reporting as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories, a significant player in the pharmaceutical industry, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a publicly traded company and does not contain new material financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- November 29, 2024 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on November 29, 2024.
Where is Dr. Reddy's Laboratories Ltd. principal executive office located?
The principal executive office of Dr. Reddy's Laboratories Ltd. is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
The filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.
What is the SIC code for Dr. Reddy's Laboratories Ltd.?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-11-29 06:19:04
Filing Documents
- drr0701_6k.htm (6-K) — 14KB
- drr0701_ex99-1.htm (EX-99.1) — 25KB
- drr0701_ex99-1img01.jpg (GRAPHIC) — 8KB
- drr0701_ex99-1img02.jpg (GRAPHIC) — 22KB
- drr0701_ex99-1img03.jpg (GRAPHIC) — 5KB
- 0001575872-24-001213.txt ( ) — 89KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 28, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3